BAD and central nervous system cancer: In particular, miR-126-3p and miR-182-5p were BAD-SPECIFIC miRNAs upregulated in both “Glioma” and “Proteoglycans in cancer” KEGG pathways, while miR-223-3p was exclusively upregulated in the second one.